Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys and Copegus in Chronic Hepatitis C
NCT01853254Phase 3Completed
- Sponsor
- Roche
- Start
- Sep 2003
- Primary completion
- Sep 2011
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 11
01
Overview
A Phase 3 trial of peginterferon alfa-2a in hepatitis C (HCV), sponsored by Roche. Started Sep 2003; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01853254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01853254.